Brief: Hikal Ltd says co does not get 483 observations for Jigani plant
10/01/2017 09:11
Jan 10 (Reuters) - Hikal Ltd HIKA.NS :
* Says API and intermediates manufacturing facility at
Jigani inspected by US FDA
* Says "zero" 483 observations were issued
Source text: http://bit.ly/2i8Eaw5
Further company coverage: HIKA.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Hikal
See all newsBrief: Hikal Begins Commercial Production At New Cgmp Panoli Facility For Personal Care
Brief: Hikal June-Quarter Consol Loss 74 Million Rupees
India's Hikal slips after quarterly profit slump
Brief: Hikal March-Quarter Consol Net Profit 144 Million Rupees
India's Hikal down after revenue reporting discrepancies flagged